Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia
- 78 Downloads
The activation of poly(ADP-ribose) polymerase (PARP) in the reperfused brain after ischemia has been assumed but never has been directly presented. Our studies indicate a different dynamic of PARP activity alteration in hippocampus during reperfusion after 3 and 10 min of transient forebrain ischemia in gerbils. The phasic stimulation of PARP activity was observed during reperfusion 15 min, 120 min, and 4 d after 3 min of ischemia with subsequent lowering of its activity close to control value on the seventh day of reperfusion. After 10 min of ischemic insult, PARP activity significantly increased from the third to the seventh day of reperfusion. The protein level of PARP was not significantly changed during reperfusion after 3 and 10 min of ischemia, with one exception: On the third day after 10 min of ischemia, PARP protein level was 28% lower compared to control; however, no enhancement of 85-kDa protein immunoreactivity was observed. These data indicate the lack of PARP cleavage in hippocampus of gerbils subjected to ischemia-reperfusion injury. The inhibitor of PARP, 3-aminobenzamide (3-AB) in a dose of 30 mg/kg b.w. (body weight) injected intravenously directly after 3 min of ischemia protects >60% of neuronal cells against death in the CA1 layer of hippocampus but has no effect after 10 min of ischemic episode. 3-AB decreased forebrain edema significantly after 3 and 10 min of ischemia. Our data indicate that PARP inhibitor(s) might offer a potent therapeutic strategy for short global ischemia. The combination of PARP inhibitor with potent antioxidant might enhance its ameliorating effect.
Index EntriesBrain ischemia poly(ADP-ribose) polymerase 3-aminobenzamide neuroprotection
Unable to display preview. Download preview PDF.
- Endres M., Scott G., Namura S., Salzman A. L., Huang P. L., Moskowitz M. A., and Szabo C. (1998) Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly (ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci. Lett. 248, 41–44.PubMedCrossRefGoogle Scholar
- Herzeg Z. and Wang Z. Q. (2001) Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat. Res. 477, 97–110.Google Scholar
- Johnson G. S. (1981) Benzamide and its derivatives inhibit nicotinamide methylation as well as ADP-ribosylation. Biochem. Int. 2, 611–617.Google Scholar
- Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Res. 79, 1431–1568.Google Scholar
- Liu J., Ying W., Massa S., Duriez P. J., Swanson R. A., Poirier G. G., and Sharp F. R. (2000) Effects of transient global ischemia and kainate on poly(ADP-ribose) polymerase (PARP) gene expression and proteolytic cleavage in gerbil and rat brains. Mol. Brain Res. 80, 7–16.PubMedCrossRefGoogle Scholar
- Martin L. J., Al-Abdulla N. A., Brambrink A. M., Kirsch J. R., Sieber F. E., and Portera-Cailliau C. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281–309.PubMedCrossRefGoogle Scholar